Bystander effect-mediated gene therapy of gliomas using genetically engineered neural stem cells
Open Access
- 18 March 2005
- journal article
- research article
- Published by Springer Nature in Cancer Gene Therapy
- Vol. 12 (7) , 600-607
- https://doi.org/10.1038/sj.cgt.7700826
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Antitumor effect of genetically engineered mesenchymal stem cells in a rat glioma modelGene Therapy, 2004
- Proliferation, migration, and differentiation of human neural stem/progenitor cells after transplantation into a rat model of traumatic brain injuryJournal of Neurosurgery, 2004
- Transplantation of prodrug-converting neural progenitor cells for brain tumor therapyCancer Gene Therapy, 2003
- Efficacy of the bystander effect in the herpes simplex virus thymidine kinase-mediated gene therapy is influenced by the expression of connexin43 in the target cellsCancer Gene Therapy, 2001
- A Phase III Clinical Evaluation of Herpes Simplex Virus Type 1 Thymidine Kinase and Ganciclovir Gene Therapy as an Adjuvant to Surgical Resection and Radiation in Adults with Previously Untreated Glioblastoma MultiformeHuman Gene Therapy, 2000
- Treatment of rat experimental brain tumors by herpes simplex virus thymidine kinase gene-transduced allogeneic tumor cells and ganciclovirCancer Gene Therapy, 2000
- Bystander Effect-Mediated Therapy of Experimental Brain Tumor by Genetically Engineered Tumor CellsHuman Gene Therapy, 1998
- Survival, Integration, and Differentiation of Neural Stem Cell Lines after Transplantation to the Adult Rat StriatumExperimental Neurology, 1997
- Evaluation of the Bystander Effect in Experimental Brain Tumors Bearing Herpes Simplex Virus–Thymidine Kinase Gene by Serial Magnetic Resonance ImagingHuman Gene Therapy, 1996
- Generation of Neurons and Astrocytes from Isolated Cells of the Adult Mammalian Central Nervous SystemScience, 1992